cortexin 2 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib inhibits the activity of cortexin 2 by selectively blocking cyclin-dependent kinase 4 (CDK4), a key regulator in the cell cycle, disrupting the progression from G1 to S phase and impeding cell proliferation. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selumetinib acts as an inhibitor by targeting mitogen-activated protein kinase (MAPK) signaling, an upstream pathway connected to cortexin 2. It disrupts the cascade, preventing activation and subsequent function of cortexin 2. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
Enzalutamide inhibits cortexin 2 through androgen receptor (AR) antagonism, disrupting AR-mediated transcriptional regulation. This interference hinders the expression of cortexin 2 and attenuates its cellular impact. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib hampers cortexin 2 function by inhibiting Src family kinases, which are linked to the downstream pathways where cortexin 2 operates. This disruption interferes with the normal signaling and activity of cortexin 2. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib impedes cortexin 2 by targeting multiple kinases, including RAF and VEGFR. By disrupting these signaling pathways, sorafenib inhibits the downstream events where cortexin 2 is involved, limiting its cellular effects. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits cortexin 2 indirectly by mTOR inhibition, a signaling pathway interconnected with cortexin 2. This interference disrupts the downstream events and diminishes the impact of cortexin 2 on cellular processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as an inhibitor by blocking PI3-kinase, a critical element in the pathway associated with cortexin 2. This disruption hampers the downstream signaling of cortexin 2, reducing its influence on cellular functions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits cortexin 2 by selectively inhibiting MEK1/2, which are upstream kinases in the MAPK signaling pathway. This interference disrupts the cascade, hindering the activation and subsequent function of cortexin 2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits cortexin 2 by selectively inhibiting p38 MAPK, a kinase involved in stress signaling pathways. This interference disrupts the downstream events, reducing the impact of cortexin 2 on cellular processes. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib hampers cortexin 2 by inhibiting BCR-ABL, c-Kit, and other tyrosine kinases. By disrupting these pathways, imatinib indirectly influences the downstream events where cortexin 2 is involved, diminishing its cellular effects. | ||||||